510(k) Report

510(k) · Cleared

Cleared

EyeBOX EBX-4.1

K242116510(k) TraditionalCleared Apr 4, 2025259-day reviewClass II21 CFR 882.1455

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oculogica, Inc. · QEA Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid

Cleared on Apr 4, 2025 as substantially equivalent to K212310 (Oculogica, Inc., 2021) and 1 other predicate after a 259-day review. Its family tree reaches back 4 generations to 2018. 1 later device descends from it.

Decided
Apr 4, 2025
Review
259 days
Class
Class II
Product code
QEA
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to DEN170091 (2018). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2021: 1 other ancestor2026: 1 descendant clearedDEN170091 · EyeBOX · Oculogica, Inc. · 2018K191183 · EyeBOX · Oculogica, Inc. · 2019K201841 · EyeBOX · Oculogica, Inc. · 2020K212310 · EyeBOX (Model EBX-4) · Oculogica, Inc. · 2021201620182020202220242026
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K212310 · EyeBOX (Model EBX-4) · Oculogica, Inc. · 2021K201841 · EyeBOX · Oculogica, Inc. · 2020K191183 · EyeBOX · Oculogica, Inc. · 2019DEN170091 · EyeBOX · Oculogica, Inc. · 20180
  1. Root · 4 generations backDEN170091 EyeBOXOculogica, Inc. · 2018
  2. 3 generations backK191183 EyeBOXOculogica, Inc. · 2019
  3. 2 generations backK201841 EyeBOXOculogica, Inc. · 2020
  4. 1 generation backK212310 EyeBOX (Model EBX-4)Oculogica, Inc. · 2021
  5. This deviceK242116 EyeBOX EBX-4.1Oculogica, Inc. · 2025
  6. Descendant · cites it directly · 0 of its ownK254086 EyeBOX SNAPOculogica, Inc. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K254086EyeBOX SNAPOculogica, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN170091EyeBOXOculogica, Inc.2018—
−3K191183EyeBOXOculogica, Inc.2019—
−2K201841EyeBOXOculogica, Inc.2020—
−1K212310EyeBOX (Model EBX-4)Oculogica, Inc.2021—
0 (this device)K242116EyeBOX EBX-4.1Oculogica, Inc.2025—
+1K254086EyeBOX SNAPOculogica, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
202110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K242116, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QEA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QEA device

  1. #1 K254086 EyeBOX SNAPscore 12.7 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K212310EyeBOX (Model EBX-4)
Summary page 5
…mmon or Usual Name: EyeBOX Classification Name: Neurology Regulatory Class: Class II Product Code: QEA Predicate Devices Oculogica, Inc. EyeBOX, Model EBX-4, K212310 SyncThink, Inc. EYE-SYNC, K202927 Device Description Oculogica’s EyeBOX EBX-4.1 is an eye-tracking device with c…
Oculogica, Inc.2021—
*K202927Eye-Sync
Summary page 5
…Name: Neurology Regulatory Class: Class II Product Code: QEA Predicate Devices Oculogica, Inc. EyeBOX, Model EBX-4, K212310 SyncThink, Inc. EYE-SYNC, K202927 Device Description Oculogica’s EyeBOX EBX-4.1 is an eye-tracking device with custom software. The device is compr…
Syncthink, Inc.20211

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K254086EyeBOX SNAPOculogica, Inc.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 1 company; a new generation was cleared every 1.3 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K254086 (Oculogica, Inc., 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QEA devices

QEA Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QEA

1in 2025

2018: 12019: 12020: 12021: 22025: 12026 (partial year): 1
2007high 2 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QEA

Too few QEA 510(k)s in any year since 2007 to give a median.

Recalls per year · QEA

No recall names QEA since 2007.

Adverse event reports per year · QEA

No MAUDE report names QEA since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20191—00
20201—00
20212—00
20220—00
20230—00
20240—00
20251—00
20261—0—

What is it indicated for?

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion, also known as

mild traumatic brain injury (mTBI), in patients 5 through 67 years of age in conjunction with a standard neurological

assessment of concussion.

A negative BOX score classification may correspond to eye movement that is consistent with a lack of concussion within

one week of injury.

A positive BOX score classification corresponds to eye movement that may be present in both patients with or without a

concussion within one week of injury.

The EyeBOX provides a set of eye-tracking metrics in relation to a reference database of uninjured individuals.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242116: EyeBOX EBX-4.1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K242116

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026